Clinical trial

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

NCT06747832

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2024-12-15

PhaseEARLY_PHASE1

Study timeline

Study start (estimated)2024-12-15Date precision: day

Registry last updated2024-12-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerunresolved

Interventions

iNK cellsDRUG

Sponsors & collaborators

Guangzhou Ruixin Biotechnological Co., LTDlead sponsor

Weifang People's Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06747832 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.